0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Editing Therapy Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-31I17252
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Editing Therapy Market Research Report 2024
BUY CHAPTERS

Global Gene Editing Therapy Market Research Report 2024

Code: QYRE-Auto-31I17252
Report
June 2024
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Editing Therapy Market

The global Gene Editing Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Gene Editing Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Editing Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Editing Therapy in Thalassemia is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Editing Therapy include CRISPR Therapeutics, Beam Therapeutics, Editas Medicine, Verve Therapeutics, Bluebird Bio, Intellia Therapeutics, Vertex Pharmaceuticals, Caribou Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Editing Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing Therapy.
The Gene Editing Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Editing Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Editing Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Editing Therapy Market Report

Report Metric Details
Report Name Gene Editing Therapy Market
Segment by Type
  • In Vivo Gene Editing
  • In Vitro Gene Editing
Segment by Application
  • Thalassemia
  • Cancer
  • Cystic Fibrosis
  • Muscular Dystrophy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CRISPR Therapeutics, Beam Therapeutics, Editas Medicine, Verve Therapeutics, Bluebird Bio, Intellia Therapeutics, Vertex Pharmaceuticals, Caribou Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Editing Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Editing Therapy Market report?

Ans: The main players in the Gene Editing Therapy Market are CRISPR Therapeutics, Beam Therapeutics, Editas Medicine, Verve Therapeutics, Bluebird Bio, Intellia Therapeutics, Vertex Pharmaceuticals, Caribou Biosciences

What are the Application segmentation covered in the Gene Editing Therapy Market report?

Ans: The Applications covered in the Gene Editing Therapy Market report are Thalassemia, Cancer, Cystic Fibrosis, Muscular Dystrophy, Others

What are the Type segmentation covered in the Gene Editing Therapy Market report?

Ans: The Types covered in the Gene Editing Therapy Market report are In Vivo Gene Editing, In Vitro Gene Editing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 In Vivo Gene Editing
1.2.3 In Vitro Gene Editing
1.3 Market by Application
1.3.1 Global Gene Editing Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Thalassemia
1.3.3 Cancer
1.3.4 Cystic Fibrosis
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Therapy Market Perspective (2019-2030)
2.2 Global Gene Editing Therapy Growth Trends by Region
2.2.1 Global Gene Editing Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Editing Therapy Historic Market Size by Region (2019-2024)
2.2.3 Gene Editing Therapy Forecasted Market Size by Region (2025-2030)
2.3 Gene Editing Therapy Market Dynamics
2.3.1 Gene Editing Therapy Industry Trends
2.3.2 Gene Editing Therapy Market Drivers
2.3.3 Gene Editing Therapy Market Challenges
2.3.4 Gene Editing Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Editing Therapy Players by Revenue
3.1.1 Global Top Gene Editing Therapy Players by Revenue (2019-2024)
3.1.2 Global Gene Editing Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Gene Editing Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Editing Therapy Revenue
3.4 Global Gene Editing Therapy Market Concentration Ratio
3.4.1 Global Gene Editing Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Therapy Revenue in 2023
3.5 Global Key Players of Gene Editing Therapy Head office and Area Served
3.6 Global Key Players of Gene Editing Therapy, Product and Application
3.7 Global Key Players of Gene Editing Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Editing Therapy Breakdown Data by Type
4.1 Global Gene Editing Therapy Historic Market Size by Type (2019-2024)
4.2 Global Gene Editing Therapy Forecasted Market Size by Type (2025-2030)
5 Gene Editing Therapy Breakdown Data by Application
5.1 Global Gene Editing Therapy Historic Market Size by Application (2019-2024)
5.2 Global Gene Editing Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Editing Therapy Market Size (2019-2030)
6.2 North America Gene Editing Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Editing Therapy Market Size by Country (2019-2024)
6.4 North America Gene Editing Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Editing Therapy Market Size (2019-2030)
7.2 Europe Gene Editing Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Editing Therapy Market Size by Country (2019-2024)
7.4 Europe Gene Editing Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Therapy Market Size (2019-2030)
8.2 Asia-Pacific Gene Editing Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Editing Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Editing Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Editing Therapy Market Size (2019-2030)
9.2 Latin America Gene Editing Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Editing Therapy Market Size by Country (2019-2024)
9.4 Latin America Gene Editing Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Therapy Market Size (2019-2030)
10.2 Middle East & Africa Gene Editing Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Editing Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Editing Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Details
11.1.2 CRISPR Therapeutics Business Overview
11.1.3 CRISPR Therapeutics Gene Editing Therapy Introduction
11.1.4 CRISPR Therapeutics Revenue in Gene Editing Therapy Business (2019-2024)
11.1.5 CRISPR Therapeutics Recent Development
11.2 Beam Therapeutics
11.2.1 Beam Therapeutics Company Details
11.2.2 Beam Therapeutics Business Overview
11.2.3 Beam Therapeutics Gene Editing Therapy Introduction
11.2.4 Beam Therapeutics Revenue in Gene Editing Therapy Business (2019-2024)
11.2.5 Beam Therapeutics Recent Development
11.3 Editas Medicine
11.3.1 Editas Medicine Company Details
11.3.2 Editas Medicine Business Overview
11.3.3 Editas Medicine Gene Editing Therapy Introduction
11.3.4 Editas Medicine Revenue in Gene Editing Therapy Business (2019-2024)
11.3.5 Editas Medicine Recent Development
11.4 Verve Therapeutics
11.4.1 Verve Therapeutics Company Details
11.4.2 Verve Therapeutics Business Overview
11.4.3 Verve Therapeutics Gene Editing Therapy Introduction
11.4.4 Verve Therapeutics Revenue in Gene Editing Therapy Business (2019-2024)
11.4.5 Verve Therapeutics Recent Development
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Details
11.5.2 Bluebird Bio Business Overview
11.5.3 Bluebird Bio Gene Editing Therapy Introduction
11.5.4 Bluebird Bio Revenue in Gene Editing Therapy Business (2019-2024)
11.5.5 Bluebird Bio Recent Development
11.6 Intellia Therapeutics
11.6.1 Intellia Therapeutics Company Details
11.6.2 Intellia Therapeutics Business Overview
11.6.3 Intellia Therapeutics Gene Editing Therapy Introduction
11.6.4 Intellia Therapeutics Revenue in Gene Editing Therapy Business (2019-2024)
11.6.5 Intellia Therapeutics Recent Development
11.7 Vertex Pharmaceuticals
11.7.1 Vertex Pharmaceuticals Company Details
11.7.2 Vertex Pharmaceuticals Business Overview
11.7.3 Vertex Pharmaceuticals Gene Editing Therapy Introduction
11.7.4 Vertex Pharmaceuticals Revenue in Gene Editing Therapy Business (2019-2024)
11.7.5 Vertex Pharmaceuticals Recent Development
11.8 Caribou Biosciences
11.8.1 Caribou Biosciences Company Details
11.8.2 Caribou Biosciences Business Overview
11.8.3 Caribou Biosciences Gene Editing Therapy Introduction
11.8.4 Caribou Biosciences Revenue in Gene Editing Therapy Business (2019-2024)
11.8.5 Caribou Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Gene Editing Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of In Vivo Gene Editing
 Table 3. Key Players of In Vitro Gene Editing
 Table 4. Global Gene Editing Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Gene Editing Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Gene Editing Therapy Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Gene Editing Therapy Market Share by Region (2019-2024)
 Table 8. Global Gene Editing Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Gene Editing Therapy Market Share by Region (2025-2030)
 Table 10. Gene Editing Therapy Market Trends
 Table 11. Gene Editing Therapy Market Drivers
 Table 12. Gene Editing Therapy Market Challenges
 Table 13. Gene Editing Therapy Market Restraints
 Table 14. Global Gene Editing Therapy Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Gene Editing Therapy Market Share by Players (2019-2024)
 Table 16. Global Top Gene Editing Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Therapy as of 2023)
 Table 17. Ranking of Global Top Gene Editing Therapy Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Gene Editing Therapy Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Gene Editing Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Gene Editing Therapy, Product and Application
 Table 21. Global Key Players of Gene Editing Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Gene Editing Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Gene Editing Therapy Revenue Market Share by Type (2019-2024)
 Table 25. Global Gene Editing Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Gene Editing Therapy Revenue Market Share by Type (2025-2030)
 Table 27. Global Gene Editing Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Gene Editing Therapy Revenue Market Share by Application (2019-2024)
 Table 29. Global Gene Editing Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Gene Editing Therapy Revenue Market Share by Application (2025-2030)
 Table 31. North America Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Gene Editing Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Gene Editing Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Gene Editing Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Gene Editing Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Gene Editing Therapy Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Gene Editing Therapy Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Gene Editing Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Gene Editing Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Gene Editing Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Gene Editing Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 46. CRISPR Therapeutics Company Details
 Table 47. CRISPR Therapeutics Business Overview
 Table 48. CRISPR Therapeutics Gene Editing Therapy Product
 Table 49. CRISPR Therapeutics Revenue in Gene Editing Therapy Business (2019-2024) & (US$ Million)
 Table 50. CRISPR Therapeutics Recent Development
 Table 51. Beam Therapeutics Company Details
 Table 52. Beam Therapeutics Business Overview
 Table 53. Beam Therapeutics Gene Editing Therapy Product
 Table 54. Beam Therapeutics Revenue in Gene Editing Therapy Business (2019-2024) & (US$ Million)
 Table 55. Beam Therapeutics Recent Development
 Table 56. Editas Medicine Company Details
 Table 57. Editas Medicine Business Overview
 Table 58. Editas Medicine Gene Editing Therapy Product
 Table 59. Editas Medicine Revenue in Gene Editing Therapy Business (2019-2024) & (US$ Million)
 Table 60. Editas Medicine Recent Development
 Table 61. Verve Therapeutics Company Details
 Table 62. Verve Therapeutics Business Overview
 Table 63. Verve Therapeutics Gene Editing Therapy Product
 Table 64. Verve Therapeutics Revenue in Gene Editing Therapy Business (2019-2024) & (US$ Million)
 Table 65. Verve Therapeutics Recent Development
 Table 66. Bluebird Bio Company Details
 Table 67. Bluebird Bio Business Overview
 Table 68. Bluebird Bio Gene Editing Therapy Product
 Table 69. Bluebird Bio Revenue in Gene Editing Therapy Business (2019-2024) & (US$ Million)
 Table 70. Bluebird Bio Recent Development
 Table 71. Intellia Therapeutics Company Details
 Table 72. Intellia Therapeutics Business Overview
 Table 73. Intellia Therapeutics Gene Editing Therapy Product
 Table 74. Intellia Therapeutics Revenue in Gene Editing Therapy Business (2019-2024) & (US$ Million)
 Table 75. Intellia Therapeutics Recent Development
 Table 76. Vertex Pharmaceuticals Company Details
 Table 77. Vertex Pharmaceuticals Business Overview
 Table 78. Vertex Pharmaceuticals Gene Editing Therapy Product
 Table 79. Vertex Pharmaceuticals Revenue in Gene Editing Therapy Business (2019-2024) & (US$ Million)
 Table 80. Vertex Pharmaceuticals Recent Development
 Table 81. Caribou Biosciences Company Details
 Table 82. Caribou Biosciences Business Overview
 Table 83. Caribou Biosciences Gene Editing Therapy Product
 Table 84. Caribou Biosciences Revenue in Gene Editing Therapy Business (2019-2024) & (US$ Million)
 Table 85. Caribou Biosciences Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Gene Editing Therapy Picture
 Figure 2. Global Gene Editing Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Gene Editing Therapy Market Share by Type: 2023 VS 2030
 Figure 4. In Vivo Gene Editing Features
 Figure 5. In Vitro Gene Editing Features
 Figure 6. Global Gene Editing Therapy Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Gene Editing Therapy Market Share by Application: 2023 VS 2030
 Figure 8. Thalassemia Case Studies
 Figure 9. Cancer Case Studies
 Figure 10. Cystic Fibrosis Case Studies
 Figure 11. Muscular Dystrophy Case Studies
 Figure 12. Others Case Studies
 Figure 13. Gene Editing Therapy Report Years Considered
 Figure 14. Global Gene Editing Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Gene Editing Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Gene Editing Therapy Market Share by Region: 2023 VS 2030
 Figure 17. Global Gene Editing Therapy Market Share by Players in 2023
 Figure 18. Global Top Gene Editing Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Therapy as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Gene Editing Therapy Revenue in 2023
 Figure 20. North America Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Gene Editing Therapy Market Share by Country (2019-2030)
 Figure 22. United States Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Gene Editing Therapy Market Share by Country (2019-2030)
 Figure 26. Germany Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Gene Editing Therapy Market Share by Region (2019-2030)
 Figure 34. China Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Gene Editing Therapy Market Share by Country (2019-2030)
 Figure 42. Mexico Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Gene Editing Therapy Market Share by Country (2019-2030)
 Figure 46. Turkey Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Gene Editing Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2019-2024)
 Figure 50. Beam Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2019-2024)
 Figure 51. Editas Medicine Revenue Growth Rate in Gene Editing Therapy Business (2019-2024)
 Figure 52. Verve Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2019-2024)
 Figure 53. Bluebird Bio Revenue Growth Rate in Gene Editing Therapy Business (2019-2024)
 Figure 54. Intellia Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2019-2024)
 Figure 55. Vertex Pharmaceuticals Revenue Growth Rate in Gene Editing Therapy Business (2019-2024)
 Figure 56. Caribou Biosciences Revenue Growth Rate in Gene Editing Therapy Business (2019-2024)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure